Evolent Health Ownership
| EVH Stock | USD 27.10 0.31 1.13% |
Shares in Circulation | First Issued 2014-06-30 | Previous Quarter 112 M | Current Value 111 M | Avarage Shares Outstanding 68.8 M | Quarterly Volatility 30.5 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Evolent |
Evolent Stock Ownership Analysis
About 96.0% of the company shares are held by institutions such as insurance companies. The book value of Evolent Health was currently reported as 9.38. The company recorded a loss per share of 1.28. Evolent Health had not issued any dividends in recent years. Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. The company was founded in 2011 and is headquartered in Arlington, Virginia. Evolent Health operates under Health Information Services classification in the United States and is traded on New York Stock Exchange. It employs 3500 people. To learn more about Evolent Health call Dan McCarthy at 571 389 6000 or check out https://www.evolent.com.Besides selling stocks to institutional investors, Evolent Health also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Evolent Health's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Evolent Health's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Evolent Health Quarterly Liabilities And Stockholders Equity |
|
Evolent Health Insider Trades History
Roughly 4.0% of Evolent Health are currently held by insiders. Unlike Evolent Health's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Evolent Health's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Evolent Health's insider trades
Evolent Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Evolent Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Evolent Health backward and forwards among themselves. Evolent Health's institutional investor refers to the entity that pools money to purchase Evolent Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Eventide Asset Management, Llc | 2023-12-31 | 2.6 M | Ra Capital Management, Llc | 2023-12-31 | 2.5 M | State Street Corporation | 2023-12-31 | 2.5 M | Bellevue Group Ag | 2023-12-31 | 2.4 M | Geode Capital Management, Llc | 2023-12-31 | 2.4 M | Holocene Advisors, Lp | 2023-09-30 | 2.3 M | Farallon Capital Management, L.l.c. | 2023-12-31 | 2.2 M | Amvescap Plc. | 2023-12-31 | 2.1 M | Hood River Capital Management Llc | 2023-12-31 | 2.1 M | Fmr Inc | 2023-12-31 | 12.9 M | Vanguard Group Inc | 2023-12-31 | 10.8 M |
Evolent Health Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Evolent Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Evolent Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Evolent Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Seth Blackley over a week ago Acquisition by Seth Blackley of 75931 shares of Evolent Health at 3.84 subject to Rule 16b-3 | ||
Dan McCarthy over two months ago Disposition of 5638 shares by Dan McCarthy of Evolent Health at 34.41 subject to Rule 16b-3 | ||
Frank Williams over six months ago Exercise or conversion by Frank Williams of 19060 shares of Evolent Health subject to Rule 16b-3 | ||
Frank Williams over a year ago Exercise or conversion by Frank Williams of 400000 shares of Evolent Health subject to Rule 16b-3 | ||
Frank Williams over a year ago Exercise or conversion by Frank Williams of 9060 shares of Evolent Health subject to Rule 16b-3 |
Evolent Health Corporate Filings
F4 | 26th of April 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 9th of April 2024 An amended filing to the original Schedule 13G | ViewVerify |
10K | 23rd of February 2024 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
8K | 22nd of February 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Evolent Health Investors Sentiment
The influence of Evolent Health's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Evolent. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Evolent Health's public news can be used to forecast risks associated with an investment in Evolent. The trend in average sentiment can be used to explain how an investor holding Evolent can time the market purely based on public headlines and social activities around Evolent Health. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Evolent Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Evolent Health's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Evolent Health's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Evolent Health.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Evolent Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Evolent Health's short interest history, or implied volatility extrapolated from Evolent Health options trading.
Pair Trading with Evolent Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evolent Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evolent Health will appreciate offsetting losses from the drop in the long position's value.Moving against Evolent Stock
| 0.57 | EUDA | EUDA Health Holdings | PairCorr |
The ability to find closely correlated positions to Evolent Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evolent Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evolent Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evolent Health to buy it.
The correlation of Evolent Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evolent Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evolent Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evolent Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for Evolent Stock analysis
When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Is Evolent Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolent Health. If investors know Evolent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.28) | Revenue Per Share 17.653 | Quarterly Revenue Growth 0.454 | Return On Assets 0.0086 | Return On Equity (0.11) |
The market value of Evolent Health is measured differently than its book value, which is the value of Evolent that is recorded on the company's balance sheet. Investors also form their own opinion of Evolent Health's value that differs from its market value or its book value, called intrinsic value, which is Evolent Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolent Health's market value can be influenced by many factors that don't directly affect Evolent Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.